Instruction for use: Montevizin

Trade name of the drug – Montevizin

Active substance: Tetryzoline

ATX code S01GA02 Tetryzoline

Pharmacotherapeutic group:

Alpha-agonists [alpha agonists]

Alpha-agonists [Ophthalmic agents]

The nosological classification (ICD-10)

H11.4 Other conjunctival vascular disease and cysts

Swelling of the conjunctiva, Secondary bloodshot eyes, conjunctival hyperemia, Flushing eye membranes

H57.1 Ocular pain

eye pain, Pain in the eyes

H57.8 Other unspecified disorders of the eye and adnexa

Intraocular hemorrhage, Inflammatory eye disease, Secondary bloodshot eyes, Burning sensation in the eyes, Protecting the front surface of the eye, Itchy eyes, Xerosis, Itching and burning eyes, Dry eye syndrome, Dry eye, xerophthalmia

H57.9 Violation of the eye and adnexa, unspecified

Allergic reactions ophthalmic, Allergic blepharitis, Symptoms of eye irritation, The syndrome of visual fatigue, Eye diseases, Spontaneous blockade angle opposite eye, Fatigue and pain in the eyes, Burning sensation in the eye, Ocular allergy, Allergic eye disease, Age-related changes in the eye structures, Eye disease, ophthalmopathy, Eye disease on the background of hyperthyroidism, Foreign body sensation in the eye, eye irritation, Eye Irritation sun, Conjunctival irritation when using contact lenses, Eye irritation shells, eye fatigue, Vascular eye disease, Age-related eye diseases, Iatrogenic blockade angle opposite eye, irritation of the conjunctiva, Irritation of the eyes, Eye irritation, Overvoltage and eye fatigue, Increased eye fatigue after visual loads, infiltrative ophthalmopathy

T78.4 Allergy, unspecified

Allergic reactions to insulin, Allergic reactions to insect stings, Allergic reactions similar to systemic lupus erythematosus, Allergic diseases, Allergic diseases of mucous membranes, Allergic diseases and conditions resulting from increased release of histamine, Allergic diseases of mucous membranes, Allergic symptoms, Allergic symptoms in the mucous membranes, Allergic reactions, Allergic reactions caused by insect bites, Allergic reactions, Allergic conditions, Allergic laryngeal edema, allergopathy, allergic conditions, Allergy, House dust allergy, Anaphylaxis, Cutaneous reactions to medications, Skin reaction to insect stings, Cosmetic allergy, Drug allergy, Acute allergic reaction, Laryngeal edema allergic genesis and background radiation, Food and drug allergy

Y97 factors associated with environmental pollution

Atmospheric pollution, Accommodation in ecologically unfavorable regions and work in harmful conditions of production, Inhaled allergens, Exposure to environmental hazards, The impact of environmental factors, The impact of adverse environmental conditions, Exposure to chemical agents,Environmental risks, Areas of concern

Composition

Eye drops 1 ml

active substance:

tetryzoline hydrochloride 0.5 mg

Excipients: benzalkonium chloride - 0.1 mg; disodium edetate dihydrate - 1 mg; sodium chloride - 1.8 mg; boric acid - 12 mg; sodium tetraborate decahydrate - 0,57 mg; Water for injection - up to 1 ml

Pharmacological Properties of MontevizinPharmachologic effect
vasoconstrictor, decongestant

Dosage and Administration

Locally, for 1-2 drops into each conjunctival sac 2-3 times a day.

If no improvement within 48 hours, further treatment is necessary to stop and consult a doctor.

release Form

Eye drops, 0.05%. Colorless glass vial, sealed with a rubber stopper with a metallic cap, 10 ml. 1 fl. together with the dosing nozzle in the paper cartons.

Storage conditions of Montevizin

In the dark place at a temperature of 15-25 ° C.

Keep out of the reach of children.
Shelf life of Montevizin

3 years.

Do not use beyond the expiration date printed on the package.

Available without prescription.